Personal care brands' role in prevention of coronavirus

May 20, 2020
Accelerating Materials Innovation More...
Very important

Unilever recently published new patents detailing an emulsion coating technology for its personal care and cosmetic products that acts as a film to prevent external pollutants (including microorganisms) from lingering on a person's skin. Dow Personal Care has been developing similar technology for a while, but such innovations could be attractive to consumers amid the coronavirus pandemic as preventative measures. While details of the technology are unclear, clients should move quickly to develop or secure access to their own technology options in this field and watch for the reception of any initial product launches.

For the original news article, click here .

Further Reading

Fisher Wallace electrocutes the bioelectronics market

Case Study | November 25, 2019

Fisher Wallace is a company best known for late‑night infomercials on both television and YouTube channels for a product that treats depression, chronic pain, and insomnia with electricity. Specifically, the company uses transcranial alternating current stimulation (tACS) in the form of a ... Not part of subscription

How Aveeno and other brands are beginning to communicate the skin microbiome to consumers

Case Study | March 26, 2020

The skin microbiome is poised to revolutionize the personal care space, with more effective products and the potential for more personalized skin care treatments. Yet, all skin care products impact the host‑microorganism relationship. As skin microbiome science becomes commonplace and brands use the... Not part of subscription

Emerging go-to-market strategies overcome regulatory and reimbursement hurdles to tap into the $4 trillion health and wellness market

Analyst Insight | December 02, 2020

Currently, the most common approach to a new healthcare solution is building it with a particular set of insurance reimbursement codes in mind (see this insight), getting clinical validation as part of the regulatory approval process, and deploying to the market with a reimbursement plan already in ... Not part of subscription